Babool is the more Indian-owned choice
Babool scores 86/100 vs Sensodyne at 13/100 on ownership — and it's Indian-owned.
86
Babool
13
Sensodyne
Brand Comparison
Babool vs Sensodyne
Quantify ownership structure, origin, and control signals in one view.
Derived from documented disclosures and scored consistently.
Indian-owned profile
Babool
India ownership score: 86/100
Foreign-owned profile
Sensodyne
India ownership score: 13/100
Comparison Fit
These brands map as direct alternatives within Oral Care.
Profile match: segment:oral care
Ownership Insight
Babool is Indian-owned. Sensodyne is owned by GSK India, headquartered in United Kingdom.
Score Breakdown
Equity ownership
Babool: 72%
Sensodyne: 0%
Manufacturing presence
Babool: 95%
Sensodyne: 40%
Revenue retention
Babool: 0%
Sensodyne: 30%
Strategic control
Babool: 100%
Sensodyne: 0%
Side-by-side Details
| Feature | Babool | Sensodyne |
|---|---|---|
| Country of origin | India | United Kingdom |
| Headquarters | Ghaziabad, Uttar Pradesh | London |
| Founded | 1970 | 1961 |
| Parent company | Dabur India | GSK India |
| Parent company country | India | United Kingdom |
| Manufacturing in India | 95% | 40% |
| Revenue retained in India | 0% | 30% |
| Ownership type | Indian Public Company | Foreign Multinational |
| Strategic control | India | United Kingdom |
More comparisons in Oral Care
Indian Competitors
Frequently Asked Questions
Which is more Indian — Sensodyne or Babool?
Babool is more Indian with a score of 86/100 vs Sensodyne's 13/100.
Is Sensodyne Indian-owned?
Sensodyne is foreign-controlled with an Indian ownership score of 13/100, owned by GSK India (United Kingdom).
Is Babool Indian-owned?
Babool is Indian-owned with an Indian ownership score of 86/100.
Who owns Sensodyne?
Sensodyne is owned by GSK India (United Kingdom).
Who owns Babool?
Babool is owned by Dabur India Ltd (India).